Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027070 |
---|---|
Receipt number | R000031003 |
Scientific Title | Clinical trial of immunomodulatory therapy using anti-thymocyte globulin and pegfilgrastim for recently onset type 1 diabetes |
Date of disclosure of the study information | 2017/04/21 |
Last modified on | 2021/04/22 09:02:38 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/04/19 22:04:15 | ||
2 | Update | 2017/04/27 17:00:17 | Primary outcomes Primary outcomes |
|
3 | Update | 2019/04/22 12:58:33 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Organization Organization Address Address Tel |
|
4 | Update | 2019/04/22 13:03:08 | Date of IRB Last follow-up date Date analysis concluded |
|
5 | Update | 2019/10/21 13:24:44 | Organization Organization Division name Division name Zip code Address Address TEL Organization Organization Division name Division name Zip code Address Address TEL Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Institute Organization Organization Organization Category of Funding Organization |
|
6 | Update | 2020/10/26 11:30:06 | Last follow-up date Date analysis concluded |
|
7 | Update | 2021/04/22 09:02:06 | Recruitment status |
|
8 | Update | 2021/04/22 09:02:38 | Number of participants that the trial has enrolled |